CD163 and tuberculosis: We found significantly higher levels in TB-IRIS patients vs. non-IRIS controls at baseline of sCD163 (median 3638 ng/mL, IQR: 3411–3880 ng/mL vs. 3257 ng/mL, IQR: 2823–3343 ng/mL, P<0.001) and sTF (median 32.5 pg/mL, IQR: 19.3–52.1 pg/mL vs. 13.9 pg/mL, IQR: 10.2–28.2 pg/mL, P<0.001), whereas sCD14 was significantly lower at baseline (median 3.8 μg/mL, IQR: 3.2–4.4 μg/mL vs. 5.5 μg/mL, IQR: 4.4–6.7 μg/mL, P<0.001).